256 related articles for article (PubMed ID: 6318777)
21. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
Waldo FB; West CD
Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of C1 and concentration dependence of its activation kinetics.
Kilchherr E; Fuchs H; Tschopp J; Engel J
Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
[TBL] [Abstract][Full Text] [Related]
23. The relationship between the binding ability and the rate of activation of the complement component C1.
Folkerd EJ; Gardner B; Hughes-Jones NC
Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
[TBL] [Abstract][Full Text] [Related]
24. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
Thielens NM; Illy C; Bally IM; Arlaud GJ
Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
[TBL] [Abstract][Full Text] [Related]
25. C1 inactivator-C1s complexes in inflammatory joint disease.
Inman RD; Harpel PC
Clin Exp Immunol; 1983 Sep; 53(3):521-8. PubMed ID: 6604603
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.
Niven IP; Whaley K
Rheumatol Int; 1986; 6(5):205-8. PubMed ID: 3492025
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of RHP and of unbound C1q in rheumatoid arthritis and systemic lupus erythematosus.
Rosano CL; Parhami N; Hechemy KE; Hurwitz C
Inflammation; 1988 Aug; 12(4):351-60. PubMed ID: 3262584
[TBL] [Abstract][Full Text] [Related]
29. Increased C1q binding immune complexes in Felty's syndrome: comparison with uncomplicated rheumatoid arthritis.
Hurd ER; Chubick A; Jasin HE; Ziff M
Arthritis Rheum; 1979 Jul; 22(7):697-702. PubMed ID: 454498
[TBL] [Abstract][Full Text] [Related]
30. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
Pearlstein E; Sorvillo J; Gigli I
J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
[TBL] [Abstract][Full Text] [Related]
31. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
32. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of immune complex-mediated activation of complement. Effects of agents modulating activation of, and the activated C1 complex.
Fletcher DS; Lin TY
Inflammation; 1980 Mar; 4(1):113-23. PubMed ID: 6967051
[TBL] [Abstract][Full Text] [Related]
34. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
O'Sullivan MM; Amos N; Williams BD
Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
[TBL] [Abstract][Full Text] [Related]
35. Circulating and intra-articular immune complexes in rheumatoid arthritis: a comparative study of the C1q binding and monoclonal rheumatoid factor assays.
Roberts-Thomson PJ; Neoh SH; Bradley J; Milazzo SC
Ann Rheum Dis; 1980 Oct; 39(5):438-44. PubMed ID: 7436574
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of C1q functions by RHP, a protein elevated in sera from patients with rheumatoid arthritis.
Rosano CL; Braun CB; Hechemy KE; Parhami N; Satoh PS; Hurwitz C
Complement; 1988; 5(2):57-64. PubMed ID: 3259913
[TBL] [Abstract][Full Text] [Related]
37. Influence of serum complement and rheumatoid factor on detection of immune complexes by the C1q and monoclonal rheumatoid factor solid-phase assay.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Immunol Methods; 1984 Oct; 73(2):301-11. PubMed ID: 6436384
[TBL] [Abstract][Full Text] [Related]
38. Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.
Smith AJ; Kyle V; Cawston TE; Hazleman BL
Ann Rheum Dis; 1987 Jun; 46(6):468-74. PubMed ID: 2820320
[TBL] [Abstract][Full Text] [Related]
39. Surfactant protein A regulates complement activation.
Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
[TBL] [Abstract][Full Text] [Related]
40. C1q binding and C1 activation by various isolated cellular membranes.
Storrs SB; Kolb WP; Olson MS
J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]